AstraZeneca blood cancer drug shows signs of helping COVID-19 patients
June 05, 2020 at 14:00 PM EDT
AstraZeneca's cancer drug Calquence has shown initial signs of helping hospitalised COVID-19 patients get through the worst of the disease, as researchers scramble to repurpose existing treatments to help fight the deadly infection.
